We demonstrated that resistance to CX-5461 was directly correlated with the level of Top2α protein and Top2 activity not only in mutated clones derived from a resistant tumor (Figure 1), but also in cell lines in which Top2α level was downregulated (Supplementary Figures S1 and S3). This evidence concerns the gene TOP2A and neoplasm.